Vindesine
- Generic Name
- Vindesine
- Drug Type
- Small Molecule
- Chemical Formula
- C43H55N5O7
- CAS Number
- 53643-48-4
- Unique Ingredient Identifier
- RSA8KO39WH
Overview
Vinblastine derivative with antineoplastic activity against cancer. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (antineoplastic combined chemotherapy protocols).
Background
Vinblastine derivative with antineoplastic activity against cancer. Major side effects are myelosuppression and neurotoxicity. Vindesine is used extensively in chemotherapy protocols (antineoplastic combined chemotherapy protocols).
Indication
For the treatment of acute leukaemia, malignant lymphoma, Hodgkin's disease, acute erythraemia and acute panmyelosis
Associated Conditions
- Acute Lymphoblastic Leukemia (ALL)
- Blast crisis in myelogenous leukaemia
- Malignant Melanoma
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath